These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1969655)

  • 41. [Transforming growth factor-beta: a new approach to the pathogenesis of glomerulonephritis and glomerulosclerosis].
    Witowski J; Knapowski J
    Przegl Lek; 1995; 52(9):467-73. PubMed ID: 8834649
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).
    Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD
    Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of the small latent transforming growth factor-beta with an eight cysteine repeat of its binding protein LTBP-1.
    Saharinen J; Taipale J; Keski-Oja J
    EMBO J; 1996 Jan; 15(2):245-53. PubMed ID: 8617200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulation of expression and cell surface binding of members of the transforming growth factor-beta superfamily during retinoic acid-induced osteoblastic differentiation of multipotential mesenchymal cells.
    Gazit D; Ebner R; Kahn AJ; Derynck R
    Mol Endocrinol; 1993 Feb; 7(2):189-98. PubMed ID: 8385738
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Production of and responsiveness to transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells.
    Valverius EM; Walker-Jones D; Bates SE; Stampfer MR; Clark R; McCormick F; Dickson RB; Lippman ME
    Cancer Res; 1989 Nov; 49(22):6269-74. PubMed ID: 2553252
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of N,N-dimethylformamide and extracellular matrix on transforming growth factor-beta binding to a human colon carcinoma cell line.
    Levine AE; Black B; Brattain MG
    J Cell Physiol; 1989 Mar; 138(3):459-66. PubMed ID: 2925796
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The sequence of TGF-beta 2 from Xenopus laevis.
    Rebbert ML; Bhatia-Dey N; Dawid IB
    Nucleic Acids Res; 1990 Apr; 18(8):2185. PubMed ID: 2336403
    [No Abstract]   [Full Text] [Related]  

  • 48. Transforming growth factor-beta: potential common mechanisms mediating its effects on embryogenesis, inflammation-repair, and carcinogenesis.
    Roberts AB; Sporn MB
    Int J Rad Appl Instrum B; 1987; 14(4):435-9. PubMed ID: 3308784
    [TBL] [Abstract][Full Text] [Related]  

  • 49. EGF-like domains in extracellular matrix proteins: localized signals for growth and differentiation?
    Engel J
    FEBS Lett; 1989 Jul; 251(1-2):1-7. PubMed ID: 2666164
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The cell biology of transforming growth factor beta.
    Barnard JA; Lyons RM; Moses HL
    Biochim Biophys Acta; 1990 Jun; 1032(1):79-87. PubMed ID: 2194569
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transforming growth-factor-Beta - a cytokine with multiple actions in oncology and potential clinical-applications (review).
    Kekow J; Wiedemann G
    Int J Oncol; 1995 Jul; 7(1):177-82. PubMed ID: 21552824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transforming growth factor alpha: an aromatic side chain at position 38 is essential for biological activity.
    Lazar E; Vicenzi E; Van Obberghen-Schilling E; Wolff B; Dalton S; Watanabe S; Sporn MB
    Mol Cell Biol; 1989 Feb; 9(2):860-4. PubMed ID: 2710128
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The transforming growth factor-betas. A new family of immunoregulatory molecules.
    Palladino MA; Morris RE; Starnes HF; Levinson AD
    Ann N Y Acad Sci; 1990; 593():181-7. PubMed ID: 2197960
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inflammatory and immunomodulatory roles of TGF-beta.
    Wahl SM; McCartney-Francis N; Mergenhagen SE
    Immunol Today; 1989 Aug; 10(8):258-61. PubMed ID: 2478145
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of TGF beta in mouse development.
    Akhurst RJ; Lehnert SA; Gatherer D; Duffie E
    Ann N Y Acad Sci; 1990; 593():259-71. PubMed ID: 1695826
    [No Abstract]   [Full Text] [Related]  

  • 56. Transforming growth factor-beta. Multiple actions and potential clinical applications.
    Sporn MB; Roberts AB
    JAMA; 1989 Aug; 262(7):938-41. PubMed ID: 2666683
    [No Abstract]   [Full Text] [Related]  

  • 57. Transforming growth factors and the regulation of cell proliferation.
    Lyons RM; Moses HL
    Eur J Biochem; 1990 Feb; 187(3):467-73. PubMed ID: 2406131
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chalones revisited--a possible role for transforming growth factor beta in tumour promotion.
    Parkinson K; Balmain A
    Carcinogenesis; 1990 Feb; 11(2):195-8. PubMed ID: 2137380
    [No Abstract]   [Full Text] [Related]  

  • 59. Autocrine and paracrine growth factors in tumor growth: a mathematical model.
    Michelson S; Leith J
    Bull Math Biol; 1991; 53(4):639-56. PubMed ID: 1933032
    [TBL] [Abstract][Full Text] [Related]  

  • 60. AAV-mediated Gpm6b expression supports hair cell reprogramming.
    Sun Q; Zhang L; Chen T; Li N; Tan F; Gu X; Zhou Y; Zhang Z; Lu Y; Lu J; Qian X; Guan B; Qi J; Ye F; Chai R
    Cell Prolif; 2024 Jul; 57(7):e13620. PubMed ID: 38400824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.